Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs

Abstract The National Cancer Institute’s Small Business Innovation Research Development Center (NCI SBIR) provides federal research and development funding and commercialization resources to more than 400 small businesses each year developing novel technologies to prevent, diagnose, and treat cancer...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Brittany Connors, Xing‐Jian Lou, Ashim Subedee, Kehui Zhang, Michael Weingarten, Deepa Narayanan
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Therapeutics. Pharmacology RM1-950 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/99b048b64e4f4415b7db189201213697
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:99b048b64e4f4415b7db189201213697
record_format	dspace
spelling	oai:doaj.org-article:99b048b64e4f4415b7db1892012136972021-11-19T17:51:34ZInvestor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs1752-80621752-805410.1111/cts.13119https://doaj.org/article/99b048b64e4f4415b7db1892012136972021-11-01T00:00:00Zhttps://doi.org/10.1111/cts.13119https://doaj.org/toc/1752-8054https://doaj.org/toc/1752-8062Abstract The National Cancer Institute’s Small Business Innovation Research Development Center (NCI SBIR) provides federal research and development funding and commercialization resources to more than 400 small businesses each year developing novel technologies to prevent, diagnose, and treat cancer. Although federal funding is vital for life science startups at the early stage of development, it is often insufficient to translate the technology from discovery to commercial product. Early‐stage startups must connect to follow‐on capital and resources to bring NCI‐funded technologies to patients. Most startups face challenges in securing additional funding due to lack of access to investors and strategic partners and the ability to effectively pitch their technology. In 2015, the NCI SBIR started the Investor Initiatives program to connect funded small businesses with targeted investors and strategic partners to address the aforementioned obstacles. This program leverages an extensive network of investors and partners to conduct business‐focused reviews and provide pitch coaching. The program incentivizes earlier collaborations between NCI‐funded companies and private investors through various channels. The program has supported 117 companies from years 2016–2019 to attend 27 investor showcase events. Follow‐up surveys show that the program and the assistance offered by NCI SBIR have contributed to a total of 32 completed deals as of April 29, 2020. This paper will discuss the Investor Initiatives program and its outcomes from 2016 to 2019 and demonstrate the effectiveness of a federal program that leverages public‐private partnerships to assist portfolio companies with raising follow‐on funding to accelerate the translation of research into clinical practice.Brittany ConnorsXing‐Jian LouAshim SubedeeKehui ZhangMichael WeingartenDeepa NarayananWileyarticleTherapeutics. PharmacologyRM1-950Public aspects of medicineRA1-1270ENClinical and Translational Science, Vol 14, Iss 6, Pp 2124-2131 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Therapeutics. Pharmacology RM1-950 Public aspects of medicine RA1-1270
spellingShingle	Therapeutics. Pharmacology RM1-950 Public aspects of medicine RA1-1270 Brittany Connors Xing‐Jian Lou Ashim Subedee Kehui Zhang Michael Weingarten Deepa Narayanan Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs
description	Abstract The National Cancer Institute’s Small Business Innovation Research Development Center (NCI SBIR) provides federal research and development funding and commercialization resources to more than 400 small businesses each year developing novel technologies to prevent, diagnose, and treat cancer. Although federal funding is vital for life science startups at the early stage of development, it is often insufficient to translate the technology from discovery to commercial product. Early‐stage startups must connect to follow‐on capital and resources to bring NCI‐funded technologies to patients. Most startups face challenges in securing additional funding due to lack of access to investors and strategic partners and the ability to effectively pitch their technology. In 2015, the NCI SBIR started the Investor Initiatives program to connect funded small businesses with targeted investors and strategic partners to address the aforementioned obstacles. This program leverages an extensive network of investors and partners to conduct business‐focused reviews and provide pitch coaching. The program incentivizes earlier collaborations between NCI‐funded companies and private investors through various channels. The program has supported 117 companies from years 2016–2019 to attend 27 investor showcase events. Follow‐up surveys show that the program and the assistance offered by NCI SBIR have contributed to a total of 32 completed deals as of April 29, 2020. This paper will discuss the Investor Initiatives program and its outcomes from 2016 to 2019 and demonstrate the effectiveness of a federal program that leverages public‐private partnerships to assist portfolio companies with raising follow‐on funding to accelerate the translation of research into clinical practice.
format	article
author	Brittany Connors Xing‐Jian Lou Ashim Subedee Kehui Zhang Michael Weingarten Deepa Narayanan
author_facet	Brittany Connors Xing‐Jian Lou Ashim Subedee Kehui Zhang Michael Weingarten Deepa Narayanan
author_sort	Brittany Connors
title	Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs
title_short	Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs
title_full	Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs
title_fullStr	Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs
title_full_unstemmed	Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs
title_sort	investor initiatives program: public‐private partnerships to expedite commercialization for nci‐funded small business entrepreneurs
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/99b048b64e4f4415b7db189201213697
work_keys_str_mv	AT brittanyconnors investorinitiativesprogrampublicprivatepartnershipstoexpeditecommercializationforncifundedsmallbusinessentrepreneurs AT xingjianlou investorinitiativesprogrampublicprivatepartnershipstoexpeditecommercializationforncifundedsmallbusinessentrepreneurs AT ashimsubedee investorinitiativesprogrampublicprivatepartnershipstoexpeditecommercializationforncifundedsmallbusinessentrepreneurs AT kehuizhang investorinitiativesprogrampublicprivatepartnershipstoexpeditecommercializationforncifundedsmallbusinessentrepreneurs AT michaelweingarten investorinitiativesprogrampublicprivatepartnershipstoexpeditecommercializationforncifundedsmallbusinessentrepreneurs AT deepanarayanan investorinitiativesprogrampublicprivatepartnershipstoexpeditecommercializationforncifundedsmallbusinessentrepreneurs
_version_	1718420028475310080

Investor initiatives program: Public‐private partnerships to expedite commercialization for NCI‐funded small business entrepreneurs

Ejemplares similares